China, Sept. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Finerenone on Early Albuminuria Regression in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: A Multicenter,Randomized, Double-Blind, Placebo-Controlled Clinical Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133280
Registration Time: 2026/09/23
Type: Interventional study
Primary Sponsor: The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=314733
Published by HT Digital Content Services with permission from Health Daily Digest....